Harvard Bioscience Inc (HBIO)
2.40
-0.06
(-2.44%)
USD |
NASDAQ |
Oct 04, 16:00
2.40
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Shareholders Equity (Annual): 73.07M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 73.07M |
| December 31, 2022 | 72.22M |
| December 31, 2021 | 83.40M |
| December 31, 2020 | 76.68M |
| December 31, 2019 | 81.69M |
| December 31, 2018 | 82.72M |
| December 31, 2017 | 80.90M |
| December 31, 2016 | 72.20M |
| December 31, 2015 | 77.60M |
| December 31, 2014 | 95.47M |
| December 31, 2013 | 94.48M |
| December 31, 2012 | 104.21M |
| December 31, 2011 | 95.50M |
| Date | Value |
|---|---|
| December 31, 2010 | 90.25M |
| December 31, 2009 | 75.26M |
| December 31, 2008 | 66.72M |
| December 31, 2007 | 74.14M |
| December 31, 2006 | 71.88M |
| December 31, 2005 | 68.42M |
| December 31, 2004 | 104.36M |
| December 31, 2003 | 98.88M |
| December 31, 2002 | 88.38M |
| December 31, 2001 | 66.81M |
| December 31, 2000 | 52.33M |
| December 31, 1999 | 7.984M |
| December 31, 1998 | 0.678M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
72.22M
Minimum
2022
83.40M
Maximum
2021
77.41M
Average
76.68M
Median
2020
Shareholders Equity (Annual) Benchmarks
| Bruker Corp | 1.377B |
| Azenta Inc | 2.534B |
| Bionano Genomics Inc | 96.16M |
| Akoya Biosciences Inc | 53.77M |
| Singular Genomics Systems Inc | 179.01M |